State Ledger
Company profile

Rapport Therapeutics, Inc. CIK 2012593

Ticker
RAPP (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Boston, MA 02110
Fiscal year end
2025 (FY)
Market Data
Close
$30.31
Change
-$0.38
Change %
-1.22%
Volume
10,055

RAPP · trading date Oct 12, 2026 · previous close $30.69 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$111.48M
Total assets
$512.43M
Total liabilities
$27.78M
Stockholders' equity
$484.65M
Cash & equivalents
$52.65M
Operating income
-$125.10M
Operating cash flow
-$87.47M
Capital expenditures
$616.0K

Fiscal year 2025, via 10-K filed 2026-03-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$88.09M
Free cash flow margin
—
Liabilities / assets
5.4%
Equity / assets
94.6%
CapEx / revenue
—
Operating cash flow / net income
0.78×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$111.48M $512.43M $27.78M $484.65M
2024 — -$78.31M $314.93M $9.51M $305.43M
2023 — -$34.79M $155.42M $14.48M -$25.63M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-09
Financials filed via
Form 10-K
filed 2026-03-10

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Boston, MA 02110
99 HIGH STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:35 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies